サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1696202

神経血管ステントの世界市場 - 2025年～2033年

Global Neurovascular Stents Market - 2025-2033

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
神経血管ステントの世界市場 - 2025年～2033年
出版日: 2025年03月25日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

神経血管ステントの世界市場は、2024年に12億5,175万米ドルに達し、2033年には30億4,053万米ドルに達すると予測され、予測期間2025-2033年のCAGRは10.4%で成長すると予測されています。

神経血管ステントは、さまざまな神経血管の状態を治療するために脳血管内に移植される小型のメッシュ状の管状デバイスです。弱くなったり狭くなったりした動脈を補強することで正常な血流を回復させ、脳卒中や動脈瘤破裂のリスクを低減します。これらのステントには、閉塞した脳動脈を開くための頭蓋内ステント、大きな動脈瘤や頸部の広い動脈瘤のためのフローダイバータ、急性虚血性脳卒中で血栓を除去するためのステントリトリーバ、頸動脈狭窄による脳卒中を予防するための頸動脈ステントなど、さまざまなタイプがあります。

市場力学：

促進要因と抑制要因

神経血管障害の有病率の上昇

脳卒中、動脈瘤、頸動脈疾患などの神経血管障害の有病率の上昇が、神経血管ステント市場の成長を大きく促進しています。世界人口の高齢化に伴い、これらの疾患の発生率は、特に脳血管疾患にかかりやすい高齢者の間で増加しています。

脳への血流が阻害されることで発症する虚血性脳卒中の負担が増加していることから、血流を回復させ、さらなる損傷を防ぐための治療オプションとして、神経血管ステントに対する需要が高まっています。例えば、2025年の米国国立衛生研究所の報告によると、米国では約79万5千人が脳卒中を経験し、そのうち約61万人が初発であると研究者は推定しています。脳卒中生存者の4人に1人近くが、生涯に再び脳卒中を発症することになります。虚血性脳卒中は脳への血流が阻害されることで発症し、脳卒中全体の約87％を占めています。頭蓋内レスキューステント留置術（RS）は、機械的血栓除去術（MT）失敗後の急性虚血性脳卒中に対する選択肢です。このように虚血性脳卒中患者の増加により、神経血管ステント留置術の必要性が高まっています。

さらに、頭蓋内アテローム性動脈硬化症や頭蓋内動脈瘤を患う患者の増加が、弱くなった血管を強化し、破裂のリスクを減らすように設計されたステントの採用に拍車をかけています。

神経血管ステント治療の高額費用

神経血管ステント治療のコストが高いことは、特に医療予算や保険適用が限られている新興国市場において、市場成長の大きな障壁となっています。神経血管ステントは、必要な画像診断、外科的専門知識、処置後のケアとともに、治療全体を高価なものにしており、処置の費用は複雑さや場所によって異なります。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • タイプ別スニペット
  • 素材別スニペット
  • 用途別スニペット
  • エンドユーザーによる抜粋
  • 地域別スニペット

第3章 市場力学

  • 影響要因
    • 促進要因
      • 神経血管疾患の罹患率の上昇
      • ステント技術の進歩
    • 抑制要因
      • 神経血管ステント手術の高額な費用
      • 厳格な規制承認プロセス
    • 機会
      • 低侵襲手術の需要増加
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名なプレーヤー
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学
  • 主要なオピニオンリーダー

第5章 神経血管ステント市場、タイプ別

  • 頭蓋内ステント
  • 頸動脈ステント

第6章 神経血管ステント市場、素材別

  • ポリマー
  • 金属
  • その他

第7章 神経血管ステント市場、用途別

  • 頸動脈狭窄症
  • 脳動脈瘤
  • 動静脈奇形および瘻孔
  • その他

第8章 神経血管ステント市場、エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック

第9章 神経血管ステント市場、地域別：市場分析と成長機会

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場プレーヤー
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • Stryker
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 過去および予測の製品販売
      • 製品販売量
    • 財務概要
      • 会社の収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Acandis GmbH
  • Balt Group
  • Boston Scientific Corporation
  • Terumo Corporation
  • MicroPort Scientific Corporation

第12章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: MD9362

The global neurovascular stents market reached US$ 1,251.75 million in 2024 and is expected to reach US$ 3,040.53 million by 2033, growing at a CAGR of 10.4% during the forecast period 2025-2033.

Neurovascular stents are small, mesh-like tubular devices implanted within brain blood vessels to treat various neurovascular conditions. They help restore normal blood flow by reinforcing weakened or narrowed arteries, reducing the risk of strokes and aneurysm ruptures. These stents come in different types, including intracranial stents for opening blocked brain arteries, flow diverters for large or wide-necked aneurysms, stent retrievers for removing blood clots in acute ischemic stroke, and carotid stents for preventing strokes caused by carotid artery stenosis.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurovascular Disorders

The rising prevalence of neurovascular disorders, such as stroke, aneurysms, and carotid artery disease, is significantly driving the growth of the neurovascular stents market. As the global population ages, the incidence of these conditions is increasing, particularly among older adults who are more vulnerable to cerebrovascular diseases.

The growing burden of ischemic strokes, which occur when blood flow to the brain is blocked, has led to a higher demand for neurovascular stents as a treatment option to restore blood flow and prevent further damage. For instance, according to a report by the National Institute of Health in 2025, it is stated that researchers estimate that approximately 795,000 people in the United States experience a stroke, with around 610,000 being first-time occurrences. Nearly 1 in 4 stroke survivors will suffer another stroke in their lifetime. Ischemic strokes, which occur due to blocked blood flow to the brain, account for about 87% of all stroke cases. Intracranial rescue stenting (RS) is an option for acute ischemic stroke after the failure of mechanical thrombectomy (MT). This increasing number of individuals with ischemic stroke individuals increases the need for neurovascular stenting procedures.

Additionally, the increasing number of patients suffering from intracranial atherosclerosis and intracranial aneurysms is fueling the adoption of stents designed to strengthen weakened blood vessels and reduce the risk of rupture.

High Cost of Neurovascular Stent Procedures

The high cost of neurovascular stent procedures is a significant barrier to market growth, particularly in developing regions where healthcare budgets and insurance coverage are limited. Neurovascular stents, along with the required imaging, surgical expertise, and post-procedure care, make the overall treatment expensive and the cost of the procedures varies depending on the complexity and location.

Segment Analysis

The global neurovascular stents market is segmented based on the type, material, application, end-user, and region.

Intracranial stents in the type segment is expected to dominate the neurovascular stents market

The intracranial stent segment is expected to dominate the global neurovascular stents market due to the rising incidence of ischemic strokes, intracranial atherosclerosis, and wide-necked aneurysms. As more patients suffer from cerebrovascular diseases, the demand for minimally invasive stenting solutions continues to grow. Intracranial stents provide a lifesaving alternative to traditional open surgeries, reducing recovery time and improving patient outcomes.

Technological advancements, such as drug-eluting and bioresorbable stents, are also driving adoption, as they help prevent complications like restenosis. Rising number of launches across various regions is expected to drive the segment's growth as these stents will be available for a vast range of individuals. For instance, in June 2024, MicroVention, Inc. announced the commercial launch of the LVIS EVO Intraluminal Support Device in the United States for the treatment of wide-neck intracranial aneurysms. The LVIS EVO, which has been available in Europe since 2019, has already seen over 12,000 units sold. Notably, it is the first fully visible coil-assist intracranial stent introduced to the U.S. market, marking a significant advancement in neurovascular treatment. Additionally, the aging global population is contributing to increased demand, as older adults are more susceptible to neurovascular conditions requiring stent placement.

Geographical Analysis

North America is expected to dominate the neurovascular stents market

North America is expected to dominate the global neurovascular stents market due to several key factors. The region has a high prevalence of neurovascular diseases, including stroke, aneurysms, and intracranial atherosclerosis, driving demand for advanced treatment options like neurovascular stents. For instance, according to the Brain Aneurysm Foundation, with approximately 1 in 50 people in the United States affected by brain aneurysms and an estimated 6.7 million Americans living with an unruptured aneurysm, the demand for neurovascular stents continues to rise, as around 30,000 individuals suffer a rupture each year, increasing the need for advanced neurovascular interventions to prevent life-threatening complications and driving the neurovascular stents market in North America.

The aging population further contributes to this demand, as older adults are at a higher risk of cerebrovascular conditions. The presence of leading medical device companies ensures continuous innovation and a strong pipeline of technologically advanced stents, including drug-eluting and bioresorbable stents. Additionally, well-established healthcare infrastructure, including specialized neurology centers and stroke care units, supports faster adoption of neurovascular stents in hospitals and clinics.

Competitive Landscape

The global market players in the neurovascular stents market are Stryker, Acandis GmbH, Balt Group, Boston Scientific Corporation, Terumo Corporation and MicroPort Scientific Corporation among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global neurovascular stents market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Neurovascular Disorders
      • 3.1.1.2. Advancements in Stent Technology
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Neurovascular Stent Procedures
      • 3.1.2.2. Stringent Regulatory Approval Processes
    • 3.1.3. Opportunity
      • 3.1.3.1. Rising Demand for Minimally Invasive Procedures
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Neurovascular Stents Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Intracranial Stents*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Carotid Artery Stents

6. Neurovascular Stents Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Polymers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Metal
  • 6.4. Others

7. Neurovascular Stents Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Carotid Artery Stenosis*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cerebral Aneurysms
  • 7.4. Arteriovenous Malformations and Fistulas
  • 7.5. Others

8. Neurovascular Stents Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics

9. Neurovascular Stents Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Stryker*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Acandis GmbH
  • 11.3. Balt Group
  • 11.4. Boston Scientific Corporation
  • 11.5. Terumo Corporation
  • 11.6. MicroPort Scientific Corporation

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us